Results 71 to 80 of about 5,991,558 (223)
The culprit of mesalamine intolerance: case series and literature review
BMC Gastroenterology, 2019 Background Mesalamine is a first-line drug in the treatment of inflammatory bowel diseases, while its intolerance occasionally occurs in clinical practice.
Cheng Xie +5 more
doaj +1 more source
Severe Ulcerative Colitis With Cytomegalovirus Colitis Treated by Early Surgery: A Case Report
Clinical Case Reports, Volume 14, Issue 8, August 2026.ABSTRACT Acute severe ulcerative colitis complicated by cytomegalovirus infection requires individualized management, and timely surgical intervention should be considered in carefully selected high‐risk patients who are unlikely to benefit from further medical therapy.
Hiroyuki Fujimura +4 more
wiley +1 more source
Saudi Medical Journal, 2017 Objectives: To explore renal toxicity caused by sub-acute exposure of acrylamide and to study the protective effect of 5-Aminosalicylic acid (5-ASA) and Vitamin E (vit-E)on Acrylamide (ACR) induced renal toxicity.
N. Rajeh, Najla Aldhaheri
semanticscholar +1 more source
Oral Health of Patients With Inflammatory Bowel Disease—A Cross‐Sectional Survey in Austria
Clinical and Experimental Dental Research, Volume 12, Issue 4, August 2026.ABSTRACT Objective This cross‐sectional survey aimed to assess oral health in patients with inflammatory bowel diseases (IBD) living in Austria. Methods Data collection was conducted with an online questionnaire, including when possible validated tools, covering general medical history, socioeconomic factors, IBD‐related parameters, and various oral ...
Kristina Bertl +6 more
wiley +1 more source
Case Reports in Cardiology, 2015 Mesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line. Myocarditis is recognized as a very rare possible side effect of this drug treatment. We present a case of mesalazine-
Michele Sorleto +2 more
doaj +1 more source
Food Science &Nutrition, Volume 14, Issue 8, August 2026.CP suppresses NLRP3 inflammasome activation through modulation of the gut microbiota, thereby exerting protective effects against ulcerative colitis. ABSTRACT Enteral nutrition is an important intervention for ulcerative colitis, and collagen can improve immune responses and repair the intestinal barrier.
Longyi Piao +7 more
wiley +1 more source
The Journal of Clinical Pharmacology, Volume 66, Issue 8, August 2026.Abstract This first‐in‐human study evaluated the safety, pharmacokinetics (PK), food effect, and pharmacodynamics (PD) of AJM347, a novel orally active, selective α4β7 integrin antagonist, in healthy Caucasian and Japanese adult males. The study consisted of three parts.
Tetsuya Koyama, Tatsunori Seki
wiley +1 more source
The Use of 5-Aminosalicylic Acid in Children and Adolescents With Inflammatory Bowel Disease
Journal of Clinical Gastroenterology, 2017 Background: In ulcerative colitis (UC) 5-aminosalicylic acid (5-ASA) is recommended as primary therapy for mild to moderate disease. Topical 5-ASA has been proven especially effective.
C. Sokollik +6 more
semanticscholar +1 more source
The Burden of Viral Respiratory Infections in Immunosuppressed Inflammatory Bowel Disease Patients
JGH Open, Volume 10, Issue 8, August 2026.ABSTRACT Background and Aim Due to the increasing immunosuppressant use in inflammatory bowel disease (IBD) and the risk of serious infections, this study investigates the prevalence and risk factors of respiratory pathogen detection in this population to improve patient care.
D. Huynh +3 more
wiley +1 more source
OncoTarget, 2016 Background and Aims The chemopreventive effect of 5-aminosalicylic acid (5-ASA) in patients with inflammatory bowel disease (IBD) has been widely studied; however, the results remain conflicting.
X. Qiu +3 more
semanticscholar +1 more source